Fractyl Health Inc (NASDAQ:GUTS) shares, rose in value on Friday, June 20, with the stock price up by 12.04% to the previous day’s close as strong demand from buyers drove the stock to $2.14.
Actively observing the price movement in the last trading, the stock closed the session at $1.91. Referring to stock’s 52-week performance, its high was $5.50, and the low was $0.87. On the whole, GUTS has fluctuated by 1.90% over the past month.
With the market capitalization of Fractyl Health Inc currently standing at about $104.82 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-13.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that GUTS’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of GUTS currently trading nearly 5.46% and 28.23% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 54.96, while the 7-day volatility ratio is showing 7.75% which for the 30-day chart, stands at 11.60%. Furthermore, Fractyl Health Inc (GUTS)’s beta value is 1.86, and its average true range (ATR) is 0.22.
A comparison of Fractyl Health Inc (GUTS) with its peers suggests the former has fared considerably weaker in the market. GUTS showed an intraday change of 12.04% in last session, and over the past year, it shrunk by -60.52%%.
Data on historical trading for Fractyl Health Inc (NASDAQ:GUTS) indicates that the trading volumes over the past 3 months, they’ve averaged 295.18K. According to company’s latest data on outstanding shares, there are 48.92 million shares outstanding.
Nearly 57.37% of Fractyl Health Inc’s shares belong to company insiders and institutional investors own 33.03% of the company’s shares. The stock has risen by 3.88% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GUTS stock heading into the next quarter.
